AU2002226674A1 - Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient - Google Patents
Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredientInfo
- Publication number
- AU2002226674A1 AU2002226674A1 AU2002226674A AU2002226674A AU2002226674A1 AU 2002226674 A1 AU2002226674 A1 AU 2002226674A1 AU 2002226674 A AU2002226674 A AU 2002226674A AU 2002226674 A AU2002226674 A AU 2002226674A AU 2002226674 A1 AU2002226674 A1 AU 2002226674A1
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- tricyclic
- active ingredient
- heterocyclic derivative
- drugs containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000402517 | 2000-12-28 | ||
| JP2000-402517 | 2000-12-28 | ||
| PCT/JP2001/011581 WO2002053565A1 (en) | 2000-12-28 | 2001-12-27 | Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002226674A1 true AU2002226674A1 (en) | 2003-01-23 |
| AU2002226674B2 AU2002226674B2 (en) | 2007-03-22 |
Family
ID=18866787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002226674A Ceased AU2002226674B2 (en) | 2000-12-28 | 2001-12-27 | Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US7034153B2 (en) |
| EP (2) | EP1832590B8 (en) |
| JP (2) | JP3528968B2 (en) |
| KR (1) | KR100843281B1 (en) |
| CN (2) | CN1274690C (en) |
| AT (2) | ATE375345T1 (en) |
| AU (1) | AU2002226674B2 (en) |
| BR (1) | BR0116609A (en) |
| CA (1) | CA2432148C (en) |
| CZ (1) | CZ20031777A3 (en) |
| DE (1) | DE60130924T2 (en) |
| DK (1) | DK1354884T3 (en) |
| ES (2) | ES2369837T3 (en) |
| HU (1) | HUP0303653A3 (en) |
| IL (2) | IL156609A0 (en) |
| MX (1) | MXPA03005913A (en) |
| NO (1) | NO326522B1 (en) |
| NZ (1) | NZ526712A (en) |
| PL (1) | PL363381A1 (en) |
| PT (1) | PT1354884E (en) |
| RU (1) | RU2291869C2 (en) |
| TW (1) | TWI293630B (en) |
| WO (1) | WO2002053565A1 (en) |
| ZA (1) | ZA200305003B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562965B1 (en) * | 2000-07-06 | 2003-05-13 | Bristol-Myers Squibb Pharma Company | Convergent synthesis of α-aryl-β-ketonitriles |
| ATE375345T1 (en) * | 2000-12-28 | 2007-10-15 | Ono Pharmaceutical Co | CYCLOPENTA(D)PYRAZOLO(1,5-A)PYRIMIDINE COMPOUND AS A CRF RECEPTOR ANTAGONIST |
| UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US7872133B2 (en) | 2003-06-23 | 2011-01-18 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocycle compound |
| BRPI0411923A (en) | 2003-06-25 | 2006-08-15 | Ono Pharmaceutical Co | methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof and production process thereof |
| JPWO2005061508A1 (en) * | 2003-12-22 | 2007-07-12 | 小野薬品工業株式会社 | Tricyclic heterocyclic compounds and pharmaceuticals containing the compounds as active ingredients |
| WO2005087775A1 (en) * | 2004-03-15 | 2005-09-22 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| US7319103B2 (en) * | 2004-06-30 | 2008-01-15 | Athersys, Inc. | Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| WO2006019831A1 (en) | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| WO2006019832A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| AR051780A1 (en) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | FUSIONED RING COMPOUNDS CONTAINING NITROGEN AND USING THEMSELVES |
| EP1829874B1 (en) | 2004-12-22 | 2014-02-12 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
| TW200639163A (en) | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
| PE20091439A1 (en) * | 2008-01-22 | 2009-10-19 | Takeda Pharmaceutical | TRICYCLIC COMPOUNDS AS ANTAGONISTS OF CRF |
| RU2376291C1 (en) * | 2008-05-07 | 2009-12-20 | Андрей Александрович Иващенко | SUBSTITUTED 3,5-DIAMINO-4-SULFONYL-PYRAZOLES AND 2-AMINO-3-SULFONYL-PYRAZOLO-[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THEIR PRODUCTION AND USE |
| US8309559B2 (en) * | 2008-01-24 | 2012-11-13 | Nikolay Filippovich Savchuk | (EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof |
| RU2369600C1 (en) * | 2008-01-24 | 2009-10-10 | Андрей Александрович Иващенко | SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULPHONYL-PYRAZOLO[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD OF OBTAINING THEM |
| AU2011281037B2 (en) * | 2010-07-22 | 2014-11-27 | Zafgen, Inc. | Tricyclic compounds and methods of making and using same |
| WO2012047569A1 (en) * | 2010-09-28 | 2012-04-12 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| US8927562B2 (en) | 2010-09-28 | 2015-01-06 | Merck Sharp & Dohme Corp. | Fused tricyclic inhibitors of mammalian target of rapamycin |
| CN103596929B (en) * | 2010-12-17 | 2016-10-19 | 里亚塔医药公司 | Pyrazoles and pyrimidine tricycloenones as antioxidant-inflammatory modulators |
| HUE029728T2 (en) | 2011-09-30 | 2017-03-28 | Ipsen Pharma Sas | Macrocyclic lrrk2 kinase inhibitors |
| ES2717510T3 (en) | 2014-09-17 | 2019-06-21 | Oncodesign Sa | Macrocyclic kinase inhibitors LRRK2 |
| US11220510B2 (en) | 2018-04-09 | 2022-01-11 | Incyte Corporation | Pyrrole tricyclic compounds as A2A / A2B inhibitors |
| US11634433B2 (en) * | 2019-12-03 | 2023-04-25 | Turning Point Therapeutics, Inc. | Macrocycles for use in treating disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006096A1 (en) * | 1990-10-09 | 1992-04-16 | Otsuka Pharmaceutical Co., Ltd. | Pyrimidine derivative, production thereof, and androgen inhibitor |
| US5843951A (en) * | 1995-09-28 | 1998-12-01 | Otsuka Pharmaceutical Factory Inc. | Analgesic composition of pyrazolo(1,5-A) pyrimidines |
| JP3621706B2 (en) | 1996-08-28 | 2005-02-16 | ファイザー・インク | Substituted 6,5-hetero-bicyclic derivatives |
| DE69907448T2 (en) * | 1998-06-09 | 2004-03-18 | Neurogen Corp., Branford | PYRIDO [2,3-B] INDOLICINE DERIVATIVES AND AZA ANALOGS: CRF1 SPECIFIC LIGANDS |
| PT1129096E (en) * | 1998-11-12 | 2003-09-30 | Neurocrine Biosciences Inc | CRF RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT RELATED TO THEM |
| ES2180338T3 (en) * | 1998-11-12 | 2003-02-01 | Neurocrine Biosciences Inc | CRF RECEIVER ANTAGONISTS AND RELATED METHODS. |
| ATE375345T1 (en) * | 2000-12-28 | 2007-10-15 | Ono Pharmaceutical Co | CYCLOPENTA(D)PYRAZOLO(1,5-A)PYRIMIDINE COMPOUND AS A CRF RECEPTOR ANTAGONIST |
-
2001
- 2001-12-27 AT AT01995808T patent/ATE375345T1/en active
- 2001-12-27 AT AT07111569T patent/ATE526330T1/en not_active IP Right Cessation
- 2001-12-27 DE DE60130924T patent/DE60130924T2/en not_active Expired - Lifetime
- 2001-12-27 AU AU2002226674A patent/AU2002226674B2/en not_active Ceased
- 2001-12-27 PT PT01995808T patent/PT1354884E/en unknown
- 2001-12-27 EP EP07111569A patent/EP1832590B8/en not_active Expired - Lifetime
- 2001-12-27 MX MXPA03005913A patent/MXPA03005913A/en active IP Right Grant
- 2001-12-27 NZ NZ526712A patent/NZ526712A/en unknown
- 2001-12-27 KR KR1020037008815A patent/KR100843281B1/en not_active Expired - Fee Related
- 2001-12-27 ES ES07111569T patent/ES2369837T3/en not_active Expired - Lifetime
- 2001-12-27 CN CNB018227201A patent/CN1274690C/en not_active Expired - Fee Related
- 2001-12-27 EP EP01995808A patent/EP1354884B1/en not_active Expired - Lifetime
- 2001-12-27 ES ES01995808T patent/ES2294047T3/en not_active Expired - Lifetime
- 2001-12-27 IL IL15660901A patent/IL156609A0/en unknown
- 2001-12-27 RU RU2003119138/04A patent/RU2291869C2/en not_active IP Right Cessation
- 2001-12-27 JP JP2002555088A patent/JP3528968B2/en not_active Expired - Fee Related
- 2001-12-27 DK DK01995808T patent/DK1354884T3/en active
- 2001-12-27 CZ CZ20031777A patent/CZ20031777A3/en unknown
- 2001-12-27 CN CNA2006101061544A patent/CN1896076A/en active Pending
- 2001-12-27 HU HU0303653A patent/HUP0303653A3/en unknown
- 2001-12-27 WO PCT/JP2001/011581 patent/WO2002053565A1/en not_active Ceased
- 2001-12-27 BR BR0116609-3A patent/BR0116609A/en not_active Application Discontinuation
- 2001-12-27 PL PL01363381A patent/PL363381A1/en unknown
- 2001-12-27 CA CA2432148A patent/CA2432148C/en not_active Expired - Fee Related
- 2001-12-27 US US10/250,328 patent/US7034153B2/en not_active Expired - Fee Related
- 2001-12-28 TW TW090132698A patent/TWI293630B/en not_active IP Right Cessation
-
2003
- 2003-06-24 IL IL156609A patent/IL156609A/en not_active IP Right Cessation
- 2003-06-26 NO NO20032956A patent/NO326522B1/en not_active IP Right Cessation
- 2003-06-26 ZA ZA2003/05003A patent/ZA200305003B/en unknown
- 2003-12-05 JP JP2003406938A patent/JP4217968B2/en not_active Expired - Fee Related
-
2005
- 2005-09-07 US US11/219,736 patent/US7459459B2/en not_active Expired - Fee Related
-
2008
- 2008-09-02 US US12/202,984 patent/US7807688B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002226674A1 (en) | Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient | |
| HUP0303653A3 (en) | Tricyclic and heterocyclic derivative and pharmaceutical compositions containing them as the active ingredient | |
| AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
| IL161940A0 (en) | Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient | |
| PL372084A1 (en) | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient | |
| AU7962200A (en) | Novel indole derivatives and drugs containing the same as the active ingredient | |
| IL164699A0 (en) | Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | |
| AU2300699A (en) | Amidino derivatives and drugs containing the same as the active ingredient | |
| IL144592A0 (en) | Heterocyclic aromatic compounds and pharmaceutical compositions containing the same | |
| EP1557415A4 (en) | Heterocyclic compounds and antitumor drugs containing the same as the active ingredient | |
| AU2002354054A1 (en) | Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient | |
| AU3053199A (en) | Fused thiophene derivatives and drugs containing the same as the active ingredient | |
| AU2001228811A1 (en) | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient | |
| AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
| AU3078000A (en) | Heterocyclic compounds and antitumor agents containing the same as the active ingredient | |
| AU2002232468A1 (en) | Pharmaceutical heterocyclic compounds | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
| AU1650401A (en) | Oxadiazole derivatives and drugs containing these derivatives as the active ingredient | |
| HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
| AU2001228810A1 (en) | Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient | |
| AU2001292122A1 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| AU1650501A (en) | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient | |
| AU6016000A (en) | Tricyclic compounds and drug compositions containing the same | |
| AU2023801A (en) | Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient |